Endotoxin removal devices for the treatment of sepsis and septic shock (Q37823734)

23 August 2017

1 reference

title

Endotoxin removal devices for the treatment of sepsis and septic shock (English)

1 reference

23 August 2017

0 references

1 reference

1 reference

B Davies

1

1 reference

PubMed ID

21183148

23 August 2017

J Cohen

series ordinal

2

1 reference

23 August 2017

1 January 2011

1 reference

Lancet Infectious Diseases

23 August 2017

1 reference

23 August 2017

11

1 reference

23 August 2017

1

1 reference

23 August 2017

65-71

1 reference

The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Sepsis in European intensive care units: results of the SOAP study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

International study of the prevalence and outcomes of infection in intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Toll-like receptors in the induction of the innate immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Protective capacity of polyclonal and monoclonal antibodies directed against endotoxin during experimental sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Polymyxin B: an ode to an old antidote for endotoxic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Polymyxin B sulphate protects cats against the haemodynamic and metabolic effects of E. coli endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

A new treatment for endotoxemia with direct hemoperfusion by polymyxin immobilized fiber. 1984.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Chromatographic removal of endotoxin from protein solutions by polymer particles

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Removal of gram-negative endotoxin from solutions by affinity chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Protection from endotoxemia: a rat model of plasmapheresis and specific adsorption with polymyxin B.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin B immobilized column

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Relationship between treatment resistance to hemoperfusion using a polymyxin B-immobilized fiber column and oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Blood purification for critical care medicine: endotoxin adsorption

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Changes of cytokines in direct endotoxin adsorption treatment on postoperative multiple organ failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Polymyxin B Hemoperfusion and Mortality in Abdominal Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Polymyxin B hemoperfusion and mortality in abdominal septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Endotoxin removal: how far from the evidence? The EUPHAS 2 Project

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Hemoperfusion with an immobilized polymyxin B fiber column decreases macrophage and monocyte activity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Hemoperfusion with an immobilized polymyxin B fiber column inhibits activation of vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Polymyxin B binds to anandamide and inhibits its cytotoxic effect

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

A new endotoxin adsorption device in Gram-negative sepsis: use of immobilized albumin with the MATISSE adsorber.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Effects of extracorporeal treatment with Lixelle on the mortality and inflammatory responses to endotoxin-induced shock in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

A novel adsorbent of circulating bacterial toxins and cytokines: the effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Direct hemoperfusion with a beta2-microglobulin-selective adsorbent column eliminates inflammatory cytokines and improves pulmonary oxygenation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Clinical experience with a novel endotoxin adsorbtion device in patients undergoing cardiac surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Lipopolysaccharide adsorber in abdominal septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

Preliminary report regarding the use of selective sorbents in complex cardiac surgery patients with extensive sepsis and prolonged intensive care stay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

International differences in the treatment of sepsis: are they justified?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970220-6

7 January 2021

10.1016/S1473-3099(10)70220-6

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21183148